REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
08/09/2025
Voltar para busca
Dado oficial do USPTO
DREAMED DIABETES
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: Estados Unidos
Snapshot rápido
DREAMED DIABETES
ST13
US500000079267062Classe
9, 10, 44
Pedido
79267062
Registro
6144170
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
45
Atualização mais recente
09/09/2025
Tipo de marca
Verbal
Classes Nice
9, 10, 44
Data de depósito
17/06/2019
Data de registro
08/09/2020
Data de expiração
-
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
08/09/2020
Última transação
09/09/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
16
Localização do titular
IL
Examinador
LAVACHE, LINDA
Unidade examinadora
L60
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
DreaMed Diabetes LTD.
Representantes
Alex Patel Patel & Almeida PC
Classificação técnica
Classes Nice
Classe 9Classe 10Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 9
Downloadable mobile application and recorded computer software for analysis of medical information in the field of diabetes via the internet
Classe 10
Wearable medical apparatus for the monitoring and compilation of biometric medical information in the field of diabetes; medical apparatus inserted into the human body for the monitoring and compilation of biometric medical information in the field of diabetes; medical diagnostic apparatus for the compilation of medical information and medical specimens from patients in the field of diabetes
Classe 44
Medical analysis for the treatment of persons; providing information in the field of medicine; providing information to patients in the field of administering medication; medical consultancy; medical analysis services relating to the treatment of patients; medical analysis services relating to the treatment of persons; medical care and analysis services relating to patient treatment; medical services in the field of diabetes; providing information via the Internet in the field of diabetes; advisory services relating to healthcare; advisory services relating to health
Publicações
Histórico de despachos e eventos da marca no USPTO.
45 publicações encontradas
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
14/04/2023
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
14/04/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
14/04/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
14/04/2023
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
10/01/2021
FICS
FINAL DISPOSITION NOTICE SENT TO IB
22/12/2020
FIMP
FINAL DISPOSITION PROCESSED
22/12/2020
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
08/12/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
08/09/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
23/06/2020
PUBO
PUBLISHED FOR OPPOSITION
23/06/2020
GPNX
NOTIFICATION PROCESSED BY IB
19/06/2020
RFNP
REFUSAL PROCESSED BY IB
05/06/2020
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
03/06/2020
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
03/06/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/06/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
20/05/2020
XAEC
EXAMINER'S AMENDMENT ENTERED
20/05/2020
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
20/05/2020
GNEA
EXAMINERS AMENDMENT E-MAILED
20/05/2020
CNEA
EXAMINERS AMENDMENT -WRITTEN
20/05/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
11/05/2020
GNRT
NON-FINAL ACTION E-MAILED
11/05/2020
CNRT
NON-FINAL ACTION WRITTEN
11/05/2020
DOCK
ASSIGNED TO EXAMINER
20/04/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
18/04/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
18/04/2020
ALIE
ASSIGNED TO LIE
17/04/2020
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
13/04/2020
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
10/12/2019
GNSL
LETTER OF SUSPENSION E-MAILED
10/12/2019
CNSL
SUSPENSION LETTER WRITTEN
10/12/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/12/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/12/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/12/2019
RFNT
REFUSAL PROCESSED BY IB
12/10/2019
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
26/09/2019
RFRR
REFUSAL PROCESSED BY MPU
26/09/2019
MAFR
APPLICATION FILING RECEIPT MAILED
20/09/2019
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
18/09/2019
CNRT
NON-FINAL ACTION WRITTEN
17/09/2019
DOCK
ASSIGNED TO EXAMINER
16/09/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
16/09/2019
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
12/09/2019
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace DREAMED DIABETES ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.